✦ LIBER ✦

Phase II Study of Oxaliplatin and Gemcitabine Salvage Chemotherapy in Patients with Cisplatin-Refractory Nonseminomatous Germ Cell Tumor

✍ Scribed by Ugo De Giorgi; Giovanni Rosti; Michele Aieta; Franco Testore; Luciano Burattini; Giuseppe Fornarini; Emanuele Naglieri; Giovanni Lo Re; Federica Zumaglini; Maurizio Marangolo

Book ID: 113609422
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 50
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2006.05.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-21.08: Salvage chemotherapy with pacl

MP-21.08: Salvage chemotherapy with paclitaxel, gemcitabine and nedaplatin (TGN) for cisplatin refractory germ cell tumors

✍ T. Nakamura; K. Mikami; N. Takaha; T. Shiraishi; A. Kawauchi; Y. Mizutani; T. Mi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Phase II trial of topotecan in patients

Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors

✍ Heidi Sonya Puc; Dean F. Bajorin; George J. Bosl; Alison Amsterdam; Robert J. Mo 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 171 KB

Phase II Trial of Pyrazoloacridine in Pa

Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors

✍ Jacqueline Vuky; John McCaffrey; Michelle Ginsberg; Tania Mariani; Dean F. Bajor 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 37 KB

Phase II Trial of Temozolomide in Patien

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

✍ G. Varuni Kondagunta; Jennifer Bacik; Lawrence Schwartz; Joel Sheinfeld; Dean Ba 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 41 KB

Salvage chemotherapy with paclitaxel and

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

✍ Takumi Shiraishi; Terukazu Nakamura; Kazuya Mikami; Natsuki Takaha; Akihiro Kawa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB

Recent Advances in Conventional-Dose Sal

Recent Advances in Conventional-Dose Salvage Chemotherapy in Patients with Cisplatin-Resistant or Refractory Testicular Germ Cell Tumors

✍ Dimitrios Farmakis; Melina Pectasides; Dimitrios Pectasides 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB